MERS-CoV vaccine (Baylor College of Medicine/ Brighton Biotech)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameMERS-CoV vaccine (Baylor College of Medicine/ Brighton Biotech)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBaylor College Of Medicine

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBrighton Biotech Inc Baylor College Of Medicine

Active IndicationsN/A

Inactive IndicationsCoronavirus Infections

Other Information

ATC CodeN/A